Stock Groups

U.S. buys more doses of Lilly’s COVID-19 treatment for $1.29 billion -Breaking

[ad_1]

© Reuters. FILE PHOTO A pharmaceutical manufacturing facility of Eli Lilly and Company is shown at 50 ImClone Dr in Branchburg (New Jersey), March 5, 2021. REUTERS/Mike Segar/File Photo

(Reuters) – Eli Lilly and Co announced Tuesday that the U.S. government purchased 614,000 more doses of COVID-19 anti-malarial therapy COVID-19 for $1.29 Billion.

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]